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Background
Cardiotoxic chemotherapy including anthracyclines
remains a standard of care in paediatric cancers. Recent
data suggest that heart failure secondary to chemother-
apy is, to some degree, reversible, but requires early
detection and prompt intervention. Since a substantial
proportion of paediatric patients still develop heart fail-
ure, this work aims to develop a follow-up protocol
based on cMRI to evaluate the patient’s cardiovascular
function and haemodynamics, as well as myocardial iron
overload, perfusion and viability.
Material and methods
From October 2009 to September 2010, 38 children
(mean age 7,8 years (0,3-17,6); mean BSA of 0,98m
2)
were prospectively identified as candidates for cardio-
toxic chemotherapy. All patients underwent a cMRI to
evaluate 1) systolic and diastolic function on steady-
state free precession cine and tagged imaging, 2)
myocardial perfusion and viability after Gadolinium
injections, 3) mitral and aortic flows through velocity-
encoded sequences, and 4) myocardial and liver iron
content based on T2* MRI.
Results
The study protocol was completed in all patients within
the first month of diagnosis, under general anaesthesia
for the 14 youngest patients. The mean MRI acquisition
time 40+/-9min. Systolic biventricular volumes, mass
and function as well as left ventricular (LV) diastolic
function were normal in all patients, with a mean LV EF
of 62,2+/-8% and RV EF of 49,5+/-7,2%. Although a
perfusion defect was not retrieved in any of these pre-
chemotherapy assessments, mild LV myocardial scaring
(mean of 4,5%) was frequently identified by gadolinium-
enhanced imaging. Aortic and mitral flux showed nor-
mal LV stroke volumes (mean of 3,78L/min/m
2). No
significant liver or cardiac iron overload was detected
(mean T2* of 23,6 and 33,2msec, respectively). Evalua-
tion of the inter-observer and intra-observer variability
was performed for all variables studied and confirmed
that the coefficients of determination were very strong
(R
2>0,95), as previously reported by others.
Conclusions
Our preliminary study shows that a detailed cardiovas-
cular evaluation of young patients undergoing che-
motherapy is achievable in a reasonable time in the
early phase following diagnosis. We believe that the low
intra and inter-observer variability of cMRI makes it sui-
table for a complete mid- and/or long-term follow-up of
cardiovascular function. This should allow to evaluate
the true harmful effects of cardiotoxic medications used
against paediatric cancers and to confirm the potential
role of cMRI as a first-line approach to subclinical heart
failure in children.
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